-
Glucose-lowering drug can protect the kidneys in patients with type 1 diabetes, study shows
A glucose-lowering drug commonly used in patients with type 2 diabetes, can protect the kidneys in patients with type 1 diabetes. According to results shown in a new study published in the Lancet. This can be huge and cause many to switch treatments. Chronic kidney failure is a major problem,…
-
How one IndyCar driver turned his type 1 diabetes into an advantage
Like most of us, 2020 hasn’t exactly gone to plan for IndyCar driver Charlie Kimball. Here in July, we should already be midway through the season. But the sport only waved the green flag in early June, starting a condensed 14-race season that wraps up—hopefully—in Florida in October. It promises…
-
Researchers identify unique glucose-sensing neurons that regulate blood sugar
Low blood sugar levels, known as hypoglycemia, can be a life-threatening situation, especially for people with type 1 diabetes who rely on intensive insulin therapy to prevent blood sugar from going too high. Solutions to this problem may come from a better understanding of the basic mechanisms keeping blood sugar…
-
French startup Diabeloop announces €31m Series B funding round
Grenoble, France-based startup Diabeloop has secured €31m in a Series B funding round led by Cemag Invest, with ADAG, Odyssée Venture, previous backers Supernova Invest, Air Liquide Venture Capital and others also participating. WHAT THEY DO Founded in 2015 out of a medical research project, the company’s primary product is…
-
Dexcom server outage rocks Type 1 diabetes community
Many users are outraged over what they say is inadequate communication by the company, which is using Facebook as a primary way to update patients. The company’s Twitter account is not active. Carrie Diulus, an orthopaedic spine surgeon and Type 1 diabetic who uses a Dexcom device, told MedTech Dive in…
-
Continuous glucose monitor alarm settings affect outcomes, severe hypoglycemia can lead to acute coronary syndrome
One of the week’s top stories in endocrinology was about a study that found adults with type 1 diabetes who used a higher glucose threshold for hypoglycemia alarms during continuous glucose monitor therapy spent approximately 50% less time in hypoglycemia. Findings that showed older adults with diabetes who experienced severe…
-
Tandem Diabetes Care Announces Health Canada Approval of t:slim X2 Insulin Pump with Basal-IQ Predictive Low-Glucose Suspend Technology
FANTASTIC NEWS!!!!!! SAN DIEGO–(BUSINESS WIRE)–Nov. 20, 2019– Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced Health Canada approval of the t:slim X2™ insulin pump with Basal-IQ™ technology. Basal-IQ technology, a predictive low-glucose suspend (PLGS) algorithm, utilizes sensor values from an integrated Dexcom…
-
Glucose monitoring technology ‘life or death’ for type 1 diabetes
Like every other kid nowadays, Ava Everson loves her gadgets. But not for their entertainment value. To the eight-year-old Niagara Falls girl, the gadgets she wears and holds can be life-saving technology. Ava has type 1 diabetes, a chronic, dangerous disease that can cause wild swings in blood glucose levels…
-
Happy 2019 World Diabetes Day – November 14th 2019
We wish everyone a happy World Diabetes Day. We wish we didn’t have to celebrate this, but since we are, let’s all have some cake, bolus a little and make the best of it! Here’s hoping to more accessible treatments, a cure, and most of all, GOOD HEALTH!
-
People With Diabetes May One Day Be Monitoring Glucose With an Earring
For millions of diabetics, a life without needles or the need to check blood sugar levels throughout the day would be a beacon of freedom unimagined. A project called Continuity might one day break that bondage. A continuous glucose monitoring and delivery system, Continuity just became a finalist for the…
